Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 2

2(33.3%)

Phase 1

1(16.7%)

6Total

N/A(3)

Phase 2(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT02730039Active Not Recruiting

Meaning-Centered Psychotherapy Training for Cancer Care Providers

Role: collaborator

NCT05095506Not ApplicableCompleted

Evaluation of an eHealth System to Reduce Depression and Increase Resilience After SCI

Role: collaborator

NCT02475954Not ApplicableCompleted

Telehealth Cognitive Behavioral Therapy for Depression in Parkinson's Disease (PD)

Role: collaborator

NCT02915237Phase 1Completed

Development of a Polyphenol-rich Dietary Preparation for Treating Veterans With Gulf War Illness

Role: collaborator

NCT01554839Not ApplicableCompleted

The Family of Heroes: an Evaluation of an Online Educational Tool

Role: lead

NCT00215345Phase 2Unknown

A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer

Role: lead

NCT00218205Phase 2Unknown

A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

Role: lead

All 7 trials loaded